ENGN — enGene Holdings Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeMid CapNeutral

Annual balance sheet for enGene Holdings, fiscal year end - October 31st, USD millions except per share, conversion factor applied.

	2021 October 31st	2022 October 31st	2023 October 31st	2024 October 31st	2025 October 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	11	20.4	81.5	238	194
Net Total Receivables	1.62	1.34	2.34	0.332	0.927
Prepaid Expenses
Total Other Current Assets
Total Current Assets	13.5	22.6	85.4	247	201
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	0.571	0.387	0.589	2.91	10.2
Long Term Investments
Other Long Term Assets
Total Assets	15	23.9	87	311	221
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3.22	5.1	5.26	14.7	32
Long Term Debt
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	15.4	47.4	14.5	38.6	53.8
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-0.324	-23.5	72.5	273	168
Total Liabilities & Shareholders' Equity	15	23.9	87	311	221
Total Common Shares Outstanding